• 한방안이비인후피부과학회지
• /
• 제22권3호
• /
• pp.220-227
• /
• 2009

Acquired hypohidrosis is a rare condition of unknown pathogenesis, while idiopathic cholinergic urticaria is relatively common. We report the case of a 18-year-old male with idiopathic cholinergic urticaria and acquired hypohidrosis. He presented with an intermittent pruritic eruption precipitated by mild activity, such as mild exercise or laughing, for last 4 years. He was diagnosed with cholinergic urticaria associated acquired hypohidrosis, successfully treated by herbal medicine applied Gejimahwanggakban-tang(桂枝麻黃各半湯).

• The Korean Journal of Pain
• /
• 제25권4호
• /
• pp.278-280
• /
• 2012

Cholinergic urticaria with acquired generalized hypohidrosis, and its pathophysiology is not well known. Autoimmunity to sweat glands or to acetylcholine receptors on sweat glands has been mentioned as one of the possible etiologies. Systemic steroid therapy, antihistamines, anticholinergics, and avoidance of the stimulatory situations are recommended for treatment. We experienced a case of cholinergic urticaria with acquired generalized hypohidrosis in a patient who had no other associated disease, and the symptoms eased after repeated bilateral stellate ganglion block. Stellate ganglion block normalized the elevated sympathetic tone and may relieve symptoms in patients with this condition.

• Annals of Clinical Neurophysiology
• /
• 제14권1호
• /
• pp.12-19
• /
• 2012

Thermoregulatory sweat is principal mean for homeostasis of temperature. Sweat glands have eccrine gland, apocrine gland, and apoeccrine glands. Disorders of sweating are manifested by excess (hyperhidrosis) or deficit (hypohidrosis, anhidrosis) of sweat. Hyperhidrosis can be defined as excessive sweating beyond a level required to maintain normal body temperature. The sweating can be generalized or localized (axilla, palms, soles, palmar-plantar, perineal). Usually hypohidrosis or anhidrosis may be more serious than hyperhidrosis. Hyperhidrosis is usually benign, but interferes with one's daily activities. First step for diagnostic approach for sweating disorders might be dividing them into localized or generalized, and primary or secondary forms. Treatement for hyperhidrosis include topical agents, botulinum toxin A injections, systemic anticholinergics, and sympathectomy.

• Clinical and Experimental Pediatrics
• /
• 제49권11호
• /
• pp.1180-1185
• /
• 2006

목 적 : TPM를 복용중인 간질 환아들에서 소한증 관련 증상 발생률을 확인함과 더불어, 뉴로체크($Neurocheck^{TM}$) 발한 검사를 시행하여 비침습적으로 발한 감소 관련 증상을 비교 확인하고자 하였다. 방 법 : 2004년 10월부터 2005년 7월까지 전북대학병원 소아과에 내원한 환자 중 간질로 진단받고 TPM를 투여 시작한 환자 55명중 자료가 불충분한 9명을 제외하고 46명을 대상으로 하였다. 대상 환자는 약물 투여 전과 목표 용량에 도달 한 직후 가능한 빠른 시간에 뉴로체크를 이용한 발한 기능 검사를 시행하였고, 2005년 여름 소한증과 관련된 증상 발현 유무를 면담을 통해 확인하였다. 결 과 : 저자들은 전북대학교병원 소아과에서 부분발작으로 진단 받고 TPM를 복용중인 46명의 환아들을 대상으로 비침습적인 검사인 뉴로체크를 이용하여 TPM 유발성 발한 감소 증상을 예측하고자 하였으며 더불어 TPM으로 인한 발한 감소 증상의 유병률을 알아보고자 하였으며 다음과 같은 결과를 얻었다. 1) 설문조사상 여름 기간 동안 TPM 사용 중 소한증 관련 증상 발생률은 37.0% 였으며 완전 무한증은 없었고 경증의 비율은 26.1%, 중증의 비율은 10.9% 였다. 2) 뉴로체크 발한 검사상 발한 지연은 34.8% 였으며 변화 없는 경우는 54.3%, 발한이 증가한 경우는 10.9% 였다. 3) 설문조사 결과 발한 감소 관련 증상을 보인 환아들에서 뉴로체크 검사상 발한 감소를 보이는 경우는 46명 중 13명으로 76.5% 였으며 이중 설문조사 상 경증인 경우는 75.0%, 중증인 경우는 80%의 양성률을 보였다. 4) 뉴로체크 발한 검사상 TPM 사용전보다 3분 이상 지연된 경우 3분 이하에서보다 상대적으로 중증의 비율이 높았다. 결 론 : 소아연령에서 비침습적인 뉴로체크 발한 검사 방법으로 손쉽게 발한감소를 측정할 수 있었다. 뉴로체크 검사를 이용하여 TPM 유발성 발한 감소 관련 증상을 예측 할 수 있었으며, 특히 TPM 사용 전보다 3분 이상 지연된 경우 소한증 증상 발현이 현저하여 열감 불내성, 기면 혹은 열사병에 대한 주의가 필요할 것으로 생각된다.

• Journal of Oral Medicine and Pain
• /
• 제31권2호
• /
• pp.121-126
• /
• 2006

저한성 외배엽 이형성증은 감모증, 치아의 수 또는 형태이상과 땀샘의 이상이 특징으로 나타나는 질환이다. 이중 치아 이상은 유치열, 영구치열 모두 영향을 받을 수 있으며 완전 무치증, 부분무치증이 특징이며 치아의 형태는 원추형으로 비정상적으로 나타난다. 이에 저자는 완전무치증을 가진 저한성 외배엽 이형성증 경험하였기에 이에 대한 증례보고와 함께 문헌고찰을 하고자 한다.

• 대한소아치과학회지
• /
• 제11권1호
• /
• pp.255-259
• /
• 1984

Ectodermal dysplasia is a rare hereditary abnormality of which the outstanding characteristics are hypodontia, hypohidrosis and hypotricosis. Patient afflicted with this malformation shows a typical face resembling that of congenital-syphilis. Dental abnormality (delayed eruption, oligodontia) becomes apparent in this child and causes the parents to bring him to the dentist. Prosthetic appliances are usually indicated and he must be adjusted or be remade as the child matures.

• Journal of Genetic Medicine
• /
• 제15권1호
• /
• pp.28-33
• /
• 2018

Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by the deficiency of ${\alpha}$-galactosidase A. Patients with classical FD present acroparesthesia, hypohidrosis, cornea verticillata, disseminated angiokeratoma, and microalbuminuria in childhood, and develop life-threatening renal, cardiac, and cerebrovascular complications typically after the fourth decade of life. To date, more than 700 mutations responsible for FD have been identified in the human GLA gene. Herein, we report a novel GLA mutation, c.1117_1141del25 (p.Gly373Profs*10), identified in an 11-year-old Korean boy with FD presenting early cardiac and neurologic manifestation and in other affected family members. The boy had acroparesthesia, hypohidrosis, cornea verticillata, and left ventricular hypertrophy. His mother and sister also had acroparesthesia. Two males on the mother's side had similar pain and died of unknown causes. The plasma ${\alpha}$-galactosidase A activity (4.1 nmol/hr/mg protein) of the patient was markedly lower than the mean value of the controls. The plasma level of globotriaosylsphingosine was elevated in the patient and all the carriers. We concluded the novel GLA mutation c.1117_1141del25 is a pathogenic mutation for FD, probably related to the early cardiac manifestation of FD.

• 음성과학
• /
• 제14권4호
• /
• pp.221-232
• /
• 2007

Topiramate (TPM) is a new antiepileptic drug characterized by a clinical effective reduction in seizure frequency and it represents a useful drug effective in a wide range of epileptic patients. Known side effects are represented by weight loss, hypohidrosis, anorexia, sedation, nephrolithiasis, cognitive complaints and language disorders. This study is to examine acoustic characteristics of patients with TPM. 15 patients were assessed through a Computerized Speech Lab (CSL) applied before the beginning of therapy with TPM and 3 months after medication had been stabilized. Tests had been chosen to assess voice onset time (VOT), total duration (TD), vowel formants, loudness, pitch, speaking rate, and articulation patterns. We compared the data from patients and healthy volunteers. The statistical analysis of the results did not show changes in acoustic tests, except for TD which was increased. The increase of the TD is evaluated as a deterioration of fluency. Our results suggest that patients with TPM did not experience acoustic speech changes except that fluency was declined. Unlike previous studies, the medication of TPM has nothing to do with speech problems in patients with epilepsy.

• 한방안이비인후피부과학회지
• /
• 제28권4호
• /
• pp.29-40
• /
• 2015

Objects : The aim of this study is to introduce latest research trend of cholinergic urticaria and consider results in view of Korean medicine.Methods : We investigate research papers, Chinese and Korean medicinal papers about Cholinergic Urticaria through Pubmed, CNKI(China National Knowledge Infrastructure) and OASIS(Oriental Medicine Advanced Searching Integrated System).Results : The pathogenesis of cholinergic urticaria is supposed to correlate with sweating, considering that many cholinergic urticaria patients are complicated with anhidrosis or hypohidrosis and have sweat hypersensitivity. And on the basis of those outcomes, diverse therapies on cholinergic urticaria are conducted recently.Conclusion : Korean medicinal approaches and treatment on cholinergic urticaria can be significant, accounting that sweating plays a important role in pathogenesis of cholinergic urticaria.

• Clinical and Experimental Pediatrics
• /
• 제46권11호
• /
• pp.1135-1138
• /
• 2003

저자들은 어린선과 과각화증의 특징적인 피부 소견과 결막염, 청력 소실로 KID 증후군이 진단된 환자에서 심한 성장 장애와 담즙 정체, 단백뇨가 동반된 1례를 경험하였기에 이를 보고하는 바이다.